Aug 31, 2020 | News, Regulatory
Gilead, a research-based biopharmaceutical company, has reported that their new antiviral treatment for COVID-19 Remdesivir, has just been granted an expansion on emergency use authorization (EUA) by the FDA for all patients hospitalized due to COVID-19. Originally...
Jul 17, 2020 | News, Regulatory
The European Commission (EC) has granted approval for Novartis’ Enzair Breezhaler, a drug therapy for uncontrolled asthma. The drug is utilized as a maintenance treatment for adults with asthma. “Novartis is working to reimagine medicine for people with uncontrolled...